(Q44450585)

English

Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies

scientific article published in June 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies (English)

1 reference

Europe PubMed Central

3 December 2017

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

3 December 2017

author name string

R Rodriguez

1

1 reference

Europe PubMed Central

3 December 2017

P Parker

2

1 reference

Europe PubMed Central

3 December 2017

A Nademanee

3

1 reference

Europe PubMed Central

3 December 2017

M R O'Donnell

5

1 reference

Europe PubMed Central

3 December 2017

A Stein

6

1 reference

Europe PubMed Central

3 December 2017

D S Snyder

7

1 reference

Europe PubMed Central

3 December 2017

H C Fung

8

1 reference

Europe PubMed Central

3 December 2017

A Y Krishnan

9

1 reference

Europe PubMed Central

3 December 2017

L Popplewell

10

1 reference

Europe PubMed Central

3 December 2017

S Cohen

11

1 reference

Europe PubMed Central

3 December 2017

G Somlo

12

1 reference

Europe PubMed Central

3 December 2017

M Angelopoulou

13

1 reference

Europe PubMed Central

3 December 2017

Z Al-Kadhimi

14

1 reference

Europe PubMed Central

3 December 2017

P M Falk

15

1 reference

Europe PubMed Central

3 December 2017

R Spielberger

16

1 reference

Europe PubMed Central

3 December 2017

N Kogut

17

1 reference

Europe PubMed Central

3 December 2017

F Sahebi

18

1 reference

Europe PubMed Central

3 December 2017

D Senitzer

19

1 reference

Europe PubMed Central

3 December 2017

M Slovak

20

1 reference

Europe PubMed Central

3 December 2017

J Schriber

21

1 reference

Europe PubMed Central

3 December 2017

S J Forman

22

1 reference

Europe PubMed Central

3 December 2017

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

3 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

3 December 2017

33

1 reference

Europe PubMed Central

3 December 2017

1123-1129

1 reference

Europe PubMed Central

3 December 2017

11

1 reference

Europe PubMed Central

3 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704493

0 references

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

21 January 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

21 January 2018

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

21 January 2018

Graft-versus-leukaemia: understanding and using the alloimmune response to treat haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

21 January 2018

Human minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

21 January 2018

Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

21 January 2018

Enhancement of G-CSF-induced stem cell mobilization by antibodies against the beta 2 integrins LFA-1 and Mac-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

21 January 2018

Fludarabine and melphalan-based conditioning for patients with advanced hematological malignancies relapsing after a previous hematopoietic stem cell transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

21 January 2018

Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

21 January 2018

Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

21 January 2018

Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-AB typing by polymerase-chain reaction with sequence-specific primers: more accurate, less errors, and increased resolution compared to serological typing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

7 January 2021

based on heuristic

inferred from DOI database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

7 January 2021

based on heuristic

inferred from DOI database lookup

Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704493

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704493

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44450585&oldid=2024502623"